Source: Health Canada shortage reports · Updated Jul 23, 2026
Some Atorvastatin Amlodipine products are in shortage in Canada (1 of 22 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 14, 2026.
A combination of a statin and a blood pressure medication used to lower cholesterol and blood pressure.
Products affected
1 / 22
In shortage since
Jun 23, 2026
Est. full return
Aug 14, 2026
Reports on file
56
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-AMLODIPINE-ATORVASTATIN
80MG
10MG · TABLET · APOTEX INC
DIN 02411342 · since Jun 23, 2026, est. end Aug 14, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-AMLODIPINE/ATORVASTATIN
80MG
5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362783 · ended Jul 18, 2025 · Demand increase for the drug.
Resolved
MYLAN-AMLODIPINE/ATORVASTATIN
40MG
5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362775 · ended Jul 18, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-AMLODIPINE/ATORVASTATIN
40MG
10MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362813 · ended Jul 18, 2025 · Quality Hold
Resolved
CADUET
80MG
5MG · TABLET · BGP PHARMA ULC
DIN 02273276 · ended Oct 17, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-AMLODIPINE-ATORVASTATIN
80MG
10MG · TABLET · APOTEX INC
DIN 02411342 · ended Sep 5, 2024 · Disruption of the manufacture of the drug.
Resolved
CADUET
80MG
10MG · TABLET · UPJOHN CANADA ULC
DIN 02273314 · ended Aug 22, 2024 · Disruption of the manufacture of the drug.
Resolved
MYLAN-AMLODIPINE/ATORVASTATIN
80MG
10MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02362821 · ended Aug 22, 2024 · Disruption of the manufacture of the drug.
Avoided
CADUET
10MG
10MG · TABLET · BGP PHARMA ULC
DIN 02273284 · ended Aug 22, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-AMLODIPINE-ATORVASTATIN
80MG
10MG · TABLET · APOTEX INC
DIN 02411342 · ended Jun 6, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-AMLODIPINE-ATORVASTATIN
40MG
5MG · TABLET · APOTEX INC
DIN 02411288 · ended Jun 6, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-AMLODIPINE-ATORVASTATIN
80MG
10MG · TABLET · APOTEX INC
DIN 02411342 · ended Jan 18, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 56 reports. All reports are on file with Health Canada.
What's happening
Atorvastatin Amlodipine is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Atorvastatin Amlodipine is classified under “LIPID MODIFYING AGENTS, COMBINATIONS” (ATC C10BX).
Recent changes
Jul 23, 2026
Estimated end date moved earlier : Aug 21, 2026 → Aug 14, 2026
Jul 16, 2026
Estimated end date moved earlier : Aug 28, 2026 → Aug 21, 2026
Common questions
What is Atorvastatin Amlodipine used for?
A combination of a statin and a blood pressure medication used to lower cholesterol and blood pressure.
When will Atorvastatin Amlodipine be back in stock in Canada?
The latest manufacturer estimate is Aug 14, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Atorvastatin Amlodipine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.